search icon
imnm-img

Immunome Inc, Common Stock

IMNM

NAQ

$8.95

+$0.32

(3.71%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$736.12M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
475.38K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.01
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$5.15 L
$16.81 H
$8.95

About Immunome Inc, Common Stock

Immunome, Inc., a clinical-stage biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. Its preclinical assets include IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, including IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameIMNMSectorS&P500
1-Week Return5.79%0.71%0.79%
1-Month Return4.8%-5.6%6.04%
3-Month Return-4.79%-11.72%-1.11%
6-Month Return-33.95%-10.81%-2.39%
1-Year Return-38.78%-7.12%11.69%
3-Year Return130.08%-0.57%42.29%
5-Year Return-33.46%27.64%93.12%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue--6.63M14.02M9.04M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":47.27,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":64.5,"profit":true}]
Cost of Revenue755.00K755.00K631.00K22.93M2.10M[{"date":"2020-12-31","value":3.29,"profit":true},{"date":"2021-12-31","value":3.29,"profit":true},{"date":"2022-12-31","value":2.75,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":9.17,"profit":true}]
Gross Profit(755.00K)(755.00K)(631.00K)14.02M9.04M[{"date":"2020-12-31","value":-5.39,"profit":false},{"date":"2021-12-31","value":-5.39,"profit":false},{"date":"2022-12-31","value":-4.5,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":64.5,"profit":true}]
Gross Margin(Infinity%)(Infinity%)(9.52%)100.00%100.00%[{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":-9.52,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses12.26M25.20M36.90M123.55M314.84M[{"date":"2020-12-31","value":3.89,"profit":true},{"date":"2021-12-31","value":8.01,"profit":true},{"date":"2022-12-31","value":11.72,"profit":true},{"date":"2023-12-31","value":39.24,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(12.26M)(25.20M)(36.90M)(109.53M)(305.80M)[{"date":"2020-12-31","value":-1226100000,"profit":false},{"date":"2021-12-31","value":-2520400000,"profit":false},{"date":"2022-12-31","value":-3690100000,"profit":false},{"date":"2023-12-31","value":-10953000000,"profit":false},{"date":"2024-12-31","value":-30580000000,"profit":false}]
Total Non-Operating Income/Expense(5.61M)483.00K10.00K5.45M25.67M[{"date":"2020-12-31","value":-21.87,"profit":false},{"date":"2021-12-31","value":1.88,"profit":true},{"date":"2022-12-31","value":0.04,"profit":true},{"date":"2023-12-31","value":21.22,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(17.84M)(24.71M)(36.90M)(106.81M)(292.96M)[{"date":"2020-12-31","value":-1783700000,"profit":false},{"date":"2021-12-31","value":-2471100000,"profit":false},{"date":"2022-12-31","value":-3689600000,"profit":false},{"date":"2023-12-31","value":-10680600000,"profit":false},{"date":"2024-12-31","value":-29296300000,"profit":false}]
Income Taxes(717.00K)(242.00K)617.00K560.11K(292.96M)[{"date":"2020-12-31","value":-116.21,"profit":false},{"date":"2021-12-31","value":-39.22,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":90.78,"profit":true},{"date":"2024-12-31","value":-47481.85,"profit":false}]
Income After Taxes(17.12M)(24.47M)(37.51M)(107.37M)-[{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(17.84M)(24.71M)(36.90M)(106.81M)(292.96M)[{"date":"2020-12-31","value":-1783700000,"profit":false},{"date":"2021-12-31","value":-2471100000,"profit":false},{"date":"2022-12-31","value":-3689600000,"profit":false},{"date":"2023-12-31","value":-10680600000,"profit":false},{"date":"2024-12-31","value":-29296300000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(17.12M)(24.47M)(37.51M)(106.81M)(292.96M)[{"date":"2020-12-31","value":-1712000000,"profit":false},{"date":"2021-12-31","value":-2446900000,"profit":false},{"date":"2022-12-31","value":-3751300000,"profit":false},{"date":"2023-12-31","value":-10680600000,"profit":false},{"date":"2024-12-31","value":-29296300000,"profit":false}]
EPS (Diluted)(8.50)(2.16)(3.09)(5.39)(4.89)[{"date":"2020-12-31","value":-850,"profit":false},{"date":"2021-12-31","value":-216,"profit":false},{"date":"2022-12-31","value":-309,"profit":false},{"date":"2023-12-31","value":-539,"profit":false},{"date":"2024-12-31","value":-489,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

IMNM
Cash Ratio 10.30
Current Ratio 10.49

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

IMNM
ROA (LTM) -33.54%
ROE (LTM) -69.21%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

IMNM
Debt Ratio Lower is generally better. Negative is bad. 0.10
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.90

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

IMNM
Trailing PE NM
Forward PE NM
P/S (TTM) 71.20
P/B 2.54
Price/FCF NM
EV/R 42.62
EV/Ebitda NM

FAQs

What is Immunome Inc share price today?

Immunome Inc (IMNM) share price today is $8.95

Can Indians buy Immunome Inc shares?

Yes, Indians can buy shares of Immunome Inc (IMNM) on Vested. To buy Immunome Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IMNM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Immunome Inc be purchased?

Yes, you can purchase fractional shares of Immunome Inc (IMNM) via the Vested app. You can start investing in Immunome Inc (IMNM) with a minimum investment of $1.

How to invest in Immunome Inc shares from India?

You can invest in shares of Immunome Inc (IMNM) via Vested in three simple steps:

  • Click on Sign Up or Invest in IMNM stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Immunome Inc shares
What is Immunome Inc 52-week high and low stock price?

The 52-week high price of Immunome Inc (IMNM) is $16.81. The 52-week low price of Immunome Inc (IMNM) is $5.15.

What is Immunome Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Immunome Inc (IMNM) is 2.54

What is the Market Cap of Immunome Inc?

The market capitalization of Immunome Inc (IMNM) is $736.12M

What is Immunome Inc’s stock symbol?

The stock symbol (or ticker) of Immunome Inc is IMNM

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top